PregLem SA is a Swiss-based speciality biopharmaceutical company dedicated to the development and commercialization of innovative drugs for women’s reproductive medicine. PregLem is a member of the Richter Group.
PregLem’s activities focus on developing therapies for gynaecologic conditions with significant unmet needs and that have a severe impact on the patient’s quality of life:
- Uterine Fibroids
- Endometriosis
- Infertility: Ovarian Reserve Modulation
- Post-Surgical Adhesions
